NCT03275974View on ClinicalTrials.gov

Glutamine PET Imaging Colorectal Cancer

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 27, 2021

Primary Completion Date

February 2, 2027

Study Completion Date

February 2, 2027

Conditions
RAS Wild TypeStage IV Colorectal CancerStage IVA Colorectal CancerStage IVB Colorectal Cancer
Interventions
BIOLOGICAL

Carbon C 11 Glutamine

Given by IV

BIOLOGICAL

Fluorine F 18 L-glutamate Derivative BAY94-9392

Given by IV

PROCEDURE

Positron Emission Tomography

Undergo PET scan

PROCEDURE

Blood Draw

Undergo venous blood draws

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER